Physician profile
Mark M Wittmann
NPI 1568475325
$1,917.18
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $16.61 · 2021: $19.56 · 2022: $24.78 · 2023: $178 · 2024: $1,263 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826 · Travel and Lodging: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.29 |
| Travel and Lodging | $762.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,394.74 | 2023-2024 | Evoque, Pascal, Hemosphere |
| Abiomed | $132.35 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $113.89 | 2019 | |
| Karl Storz Endoscopy-America | $61.29 | 2019 | |
| Medtronic Vascular, INC. | $58.65 | 2019 | |
| Eagle Pharmaceuticals, INC. | $46.27 | 2023-2024 | |
| Abbott Laboratories | $44.34 | 2021-2022 | |
| Bard Access Systems, INC. | $25.50 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.61 | 2020 | |
| Cvrx, INC. | $15.22 | 2025 | Barostim Neo System |
| Vyaire Medical, INC. | $8.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wittmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.